| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Aug 25, 2026 |
Merck & Co Inc
MRK
|
BUY |
$180.00
Est. +19%
|
$150.69 | $156.91 |
Pending
|
$148.74
-1.3%
|
| Aug 13, 2026 |
Abbvie Inc
ABBV
|
BUY |
$300.00
Est. +21%
|
$248.66 | $269.39 |
Pending
|
$264.40
+6.3%
|
| Jul 20, 2026 |
Moderna Inc
MRNA
|
SELL |
$25.00
Est. +60%
|
$61.82 | $52.66 (Low) |
Pending
|
$198.88
-221.7%
|
| May 18, 2026 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$860.00
Est. +37%
|
$629.36 | $859.34 |
Bullseye Hit (±1%)
|
$788.04
+25.2%
|
| May 14, 2026 |
Pfizer Inc.
PFE
|
BUY |
$26.00
Est. +0%
|
$25.96 | $29.21 |
Target Met
|
$28.67
+10.4%
|
| Dec 17, 2025 |
Pfizer Inc.
PFE
|
SELL |
$24.00
Est. +6%
|
$25.53 | $23.62 (Low) |
Precision Hit (±3%)
|
$28.67
-12.3%
|
| Dec 15, 2025 |
Gilead Sciences, Inc.
GILD
|
BUY |
$150.00
Est. +25%
|
$120.41 | $157.27 |
Target Met
|
$150.93
+25.3%
|